How Has the Hormonal Contraceptives Market Size Evolved in Recent Years?
The hormonal contraceptives market has seen considerable growth due to a variety of factors.
• The market size for hormonal contraceptives has experienced minor growth in the recent past. The market value is anticipated to increase from $14.16 billion in 2024 to approximately $14.43 billion in 2025, with a compound annual growth rate (CAGR) of 1.9%.
Factors contributing to this historic period growth can include governmental support, escalating use of contraceptives, higher pharmaceutical R&D spendings, enhanced healthcare expenditures, along with an expanded number of healthcare facilities.
How Will The Hormonal Contraceptives Market Size Evolve In The Foreseeable Future?
The hormonal contraceptives market is expected to maintain its strong growth trajectory in upcoming years.
• The market for hormonal contraceptives is projected to experience slight expansion in the upcoming years, growing to a value of $15.53 billion in 2029, with a CAGR of 1.9%.
This growth within the forecast period could be due to the rise in awareness about family planning, increased expenditure on research and development, enhanced healthcare spending, and growing partnerships among agencies. Significant trends predicted for this forecast period encompass investments in vaginal rings with a longer lifespan, embrace of AI technologies to boost medication compliance, introduction of innovative new products, commitment in eco-friendly estrogen profiles, investments in optimised progestogen only contraceptive pills, and persistent investments in long-term drug delivery systems.
Which Factors Are Boosting Growth In The Hormonal Contraceptives Market?
The rise in knowledge about hormonal contraceptives has led to a more informed and self-sufficient population, enabling people to make decisions in line with their reproductive aims and lifestyles. With more education about contraceptive alternatives, people are empowered to make more suitable decisions about their reproductive wellbeing, leading to an increase in the use of hormonal contraceptives that resonate with their family planning and lifestyle choices. For example, in September 2023, as per the data from the World Health Organization (WHO), a United Nations specialized agency based in Switzerland for international public health, the estimated global prevalence rate for contraception of any kind was 65% in 2022, whereas prevalence of modern contraceptive methods accounted for 58.7% among wed women in a union. The worldwide satisfaction rate for modern family planning methods among women between the ages of 15–49 will reach 77.5% in 2022. Heightened awareness about the benefits and use of contraceptives makes a substantial contribution to driving the hormonal contraceptives market.
What Are The Core Segments Of The Globa Hormonal Contraceptives Market?
The hormonal contraceptives market covered in this report is segmented –
1) By Product : Pills, Injectable Birth Control, Vaginal Rings, Others
2) By End User : Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers
3) By Hormones : Progestin-Only, Combined Hormones
4) By Distribution Channel : Drug Stores, Gynecology Or Fertility Clinics, E-Commerce, Other Distribution Channels
Subsegments:
1) By Pills: Combined Oral Contraceptives (COCs), Progestin-Only Pills (POPs), Emergency Contraceptive Pills
2) By Injectable Birth Control: Depot Medroxyprogesterone Acetate (DMPA), Combination Injectable Contraceptives, Subdermal Implants
3) By Vaginal Rings: NuvaRing, Annovera, Other Hormonal Vaginal Rings
4) By Others: Transdermal Patches, Intrauterine Devices (IUDs) with Hormones, Hormonal Implants, Contraceptive Tablets For Men
Pre-Book The Hormonal Contraceptives Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Trends Are Reshaping The Hormonal Contraceptives Market?
Corporations are pioneering the creation of chewable, low-dose oral contraceptives to minimize side effects. The development of this chewable contraceptive was an endeavor to decrease side effects and concurrently streamline the daily routine of contraceptive usage for patients. The product is already available for purchase over-the-counter. Major players in the production and sale of these innovative chewable low-dose oral contraceptives include Lupin Pharmaceuticals, Walter Chilcott, and Watson Pharmaceuticals.
Who Are the Key Players in the Hormonal Contraceptives Market?
Major companies operating in the hormonal contraceptives market include:
• Bayer AG
• Merck & Co. Inc
• Viatris
• Gedeon Richter
• AbbVie
• Pfizer
• Teva Pharmaceuticals
• Mayne Pharma Group Limited
• Lupin Limited
• HLL Lifecare Limited
• Amneal Pharmaceuticals
• DKT International
• Piramal Pharma Limited
• Allergan
• Afaxys Inc.
• Agile Therapeutic
• Cipla Limited
• Glenmark Pharmaceuticals
• Novartis AG
• Sun Pharmaceutical Industries Ltd.
• Apothecus Pharmaceutical Corporation
• Famy care
• Mylan Laboratories
What are the Regional Insights into the Hormonal Contraceptives Market?
North America was the largest region in the hormonal contraceptives market share in 2024. Middle East is expected to be the fastest-growing region in the global hormonal contraceptives market analysis during the forecast period. The regions covered in the hormonal contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
